Literature DB >> 18091280

A survey to determine the understanding of the conceptual basis and diagnostic tests used for brain death by neurosurgeons in Canada.

Ari R Joffe1, Natalie Anton, Vivek Mehta.   

Abstract

OBJECTIVE: To determine the understanding of the conceptual basis and diagnostic tests used for brain death (BD) by neurosurgeons in Canada.
METHODS: Between February and June 2006, a previously developed survey was mailed to every neurosurgeon in Canada.
RESULTS: Of 223 surveys mailed, 147 (66%) were returned; of these, 128 (87%) were completed and analyzed. When asked to choose a conceptual reason to explain why BD is equivalent to death, 50 (39%) chose a higher brain concept, 50 (39%) chose a prognosis concept, and 33 (26%) chose a loss of integration of the organism concept. More than half of respondents answered that BD is not compatible with electroencephalographic activity or brainstem evoked potential activity. More than one-third of respondents answered that some cerebral blood flow or a brainstem with minimal microscopic damage was not compatible with BD. Of the 90 respondents who answered that they were comfortable diagnosing BD because the conceptual basis of BD makes it equivalent to death of the patient, in their own words, 14 (16%) used a loss of integration concept, 20 (22%) used a prognosis concept, 25 (28%) used a higher brain concept, and 39 (43%) did not articulate a concept. When asked, "Are brain death and cardiac death the same state (i.e., are both death of the patient)?," 57 (45%) answered "No."
CONCLUSION: Within the neurosurgical community, a stand-alone concept of BD does not exist. There is also significant variability in the understanding of the tests that are compatible with the criterion of BD.

Entities:  

Mesh:

Year:  2007        PMID: 18091280     DOI: 10.1227/01.neu.0000303200.84994.ae

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

1.  Practice variability in brain death determination: a call to action.

Authors:  Claire N Shappell; Jeffrey I Frank; Khalil Husari; Matthew Sanchez; Fernando Goldenberg; Agnieszka Ardelt
Journal:  Neurology       Date:  2013-11-06       Impact factor: 9.910

2.  Renaissance of criticism on the concept of brain death--the role of legal medicine in the context of the interdisciplinary discussion.

Authors:  L Markert; B Bockholdt; M A Verhoff; S Heinze; M Parzeller
Journal:  Int J Legal Med       Date:  2015-07-15       Impact factor: 2.686

3.  Brain death, states of impaired consciousness, and physician-assisted death for end-of-life organ donation and transplantation.

Authors:  Joseph L Verheijde; Mohamed Y Rady; Joan L McGregor
Journal:  Med Health Care Philos       Date:  2009-05-13

4.  A survey of American neurologists about brain death: understanding the conceptual basis and diagnostic tests for brain death.

Authors:  Ari R Joffe; Natalie R Anton; Jonathan P Duff; Allan Decaen
Journal:  Ann Intensive Care       Date:  2012-02-17       Impact factor: 6.925

5.  Do the 'brain dead' merely appear to be alive?

Authors:  Michael Nair-Collins; Franklin G Miller
Journal:  J Med Ethics       Date:  2017-08-28       Impact factor: 2.903

Review 6.  The intractable problems with brain death and possible solutions.

Authors:  Ari R Joffe; Gurpreet Khaira; Allan R de Caen
Journal:  Philos Ethics Humanit Med       Date:  2021-10-09       Impact factor: 2.464

Review 7.  Healthcare Professionals' Understandings of the Definition and Determination of Death: A Scoping Review.

Authors:  Katina Zheng; Stephanie Sutherland; Laura Hornby; Lindsay Wilson; Sam D Shemie; Aimee J Sarti
Journal:  Transplant Direct       Date:  2022-03-25

8.  A Framework for Revisiting Brain Death: Evaluating Awareness and Attitudes Toward the Neuroscientific and Ethical Debate Around the American Academy of Neurology Brain Death Criteria.

Authors:  Krishanu Chatterjee; Mohamed Y Rady; Joseph L Verheijde; Richard J Butterfield
Journal:  J Intensive Care Med       Date:  2021-02-22       Impact factor: 3.510

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.